Bryan J. McMichael - 22 Jan 2026 Form 4 Insider Report for Coherus Oncology, Inc. (CHRS)

Role: Chief Financial Officer
Signature: /s/ Bryan J. McMichael
Issuer symbol: CHRS
Transactions as of: 22 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 26 Jan 2026, 16:39:43 UTC
Previous filing: 22 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
McMichael Bryan J	Chief Financial Officer	C/O COHERUS ONCOLOGY, INC., 333 TWIN DOLPHIN DRIVE, SUITE 600, REDWOOD CITY	/s/ Bryan J. McMichael	26 Jan 2026	0001944868

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CHRS	Common Stock	Award	$0	+112,500	+530%	$0.000000	133,736	22 Jan 2026	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CHRS	Stock Option (Right to Buy)	Award	$0	+225,000		$0.000000	225,000	22 Jan 2026	Common Stock	225,000	$1.59	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 50% of the RSUs vest on May 20, 2027 and 50% of the RSUs vest on March 20, 2029, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
F2	The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of January 22, 2026 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.